Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer
Clinical trial NCT01829113 · COMPLETED
Trial details
- NCT number
- NCT01829113
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2017-04-19
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.